1. Home
  2. KODK vs ORGO Comparison

KODK vs ORGO Comparison

Compare KODK & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eastman Kodak Company Common New

KODK

Eastman Kodak Company Common New

HOLD

Current Price

$8.86

Market Cap

705.6M

ML Signal

HOLD

Logo Organogenesis Holdings Inc.

ORGO

Organogenesis Holdings Inc.

HOLD

Current Price

$4.77

Market Cap

624.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KODK
ORGO
Founded
1880
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
705.6M
624.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
KODK
ORGO
Price
$8.86
$4.77
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
$8.00
AVG Volume (30 Days)
2.0M
3.2M
Earning Date
11-06-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,045,000,000.00
$465,218,000.00
Revenue This Year
N/A
$8.14
Revenue Next Year
N/A
$6.33
P/E Ratio
N/A
N/A
Revenue Growth
N/A
2.24
52 Week Low
$4.93
$2.61
52 Week High
$9.31
$7.08

Technical Indicators

Market Signals
Indicator
KODK
ORGO
Relative Strength Index (RSI) 70.42 43.04
Support Level $7.50 $4.92
Resistance Level $8.67 $5.83
Average True Range (ATR) 0.43 0.35
MACD 0.11 -0.13
Stochastic Oscillator 82.12 0.68

Price Performance

Historical Comparison
KODK
ORGO

About KODK Eastman Kodak Company Common New

Eastman Kodak Co is a United States-based company. It operates through several business segments; Print, Brand, and Advanced Materials and Chemicals. The Print segment which derives the majority of revenue includes products like digital offset plate offerings and computer-to-plate imaging solutions, high-quality digital printing solutions using electrically charged toner-based technology, production press systems, consumables, inkjet components, software and services. Geographically, the company generates revenue from the United States, Canada, Europe, Middle East and Africa, Asia Pacific, and Latin America.

About ORGO Organogenesis Holdings Inc.

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

Share on Social Networks: